A1Cantus vs. Placebo
ConditionType 2 Diabetes
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age21-75
SponsorUniversity of California, Riverside
About this trial
The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.
Eligibility criteria
Qualifiers
Adults 21 years of age or older and not older than 75 recruited from UCR Health
Clinical diagnosis of type II DM with Ha1c >= 8 but less than or equal to 10
Stable medications for at least 6 months
Speak Spanish and/or English
Disqualifiers
Patients <21 years of age, who do not have type II DM, whose Ha1c is less than 8 or > 10,
Have major complications of diabetes, including CKD, diabetic retinopathy, ADVD risk > 5, or history of CVD/stroke
Do not speak and understand either English or Spanish well
Allergic to cinnamon
Trial design
Treatments tested in this trial
- A1C Drink
- Placebo drink
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of California, Riverside
Lead sponsor
A1Cantus
Collaborator
Source ClinicalTrials.gov